Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06557317 · ClinicalTrials.gov registry record · NA

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

A NA study of Diabetes Mellitus, Type 2 and Overweight, sponsored by Cornell University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06557317: Recruiting NA study of Diabetes Mellitus, Type 2 and Overweight, sponsored by Cornell University.

NCT06557317 is a NA study of Diabetes Mellitus, Type 2 and Overweight that is actively recruiting participants, run by Cornell University. The registered enrollment target is 60 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06557317, a NA study of Diabetes Mellitus, Type 2 and Overweight, is actively recruiting participants, sponsored by Cornell University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.

Interventions

  • BEHAVIORAL Black Girls for Wellness In-Person

Study Locations (1)

New York

  • Brownsville Neighborhood Health Action Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-08
Est. Completion 2024-12-31
Phase NA
Cornell University

66 total trials

What NCT06557317 shows while recruiting

NCT06557317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).

The record links to 10 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Black Girls for Wellness In-Person is the first listed.

NCT06557317 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06557317 about?

NCT06557317 is a clinical study titled "In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes". The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.

What is the current status of trial NCT06557317?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-08. Estimated completion is 2024-12-31.

What conditions does trial NCT06557317 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Overweight, Pediatric Obesity, Childhood Obesity, Metabolic Disease.

What interventions are being tested in trial NCT06557317?

The interventions under investigation include: Black Girls for Wellness In-Person (BEHAVIORAL).

Who is sponsoring clinical trial NCT06557317?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06557317 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06557317's enrollment target sits among peer trials

60 246th of 348 higher than 98 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06557317, the US trial registry maintained by the National Library of Medicine. NCT06557317 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.